Actively Recruiting

Phase 2
Age: 18Years +
All Genders
NCT06451861

Randomized Study of ABC-14 Regimen Compared With "3+7" Standard Induction Therapy or AB-14 for ND AML

Led by Guangdong Provincial People's Hospital · Updated on 2025-11-17

240

Participants Needed

13

Research Sites

149 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

To compare the efficacy and safty of ABC-14 regimen with the traditional "3+7" regimen or AB-14 regimen in the treatment of newly diagnosed acute myeloid leukaemia

CONDITIONS

Official Title

Randomized Study of ABC-14 Regimen Compared With "3+7" Standard Induction Therapy or AB-14 for ND AML

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosed with AML according to WHO2022 criteria (non-APL) and have not received systemic anti-leukemia therapy except hydroxyurea or low-dose cytarabine
  • Age 18 years or older
  • ECOG performance status of 0 to 4
  • Fertile women agree to use effective contraception during treatment and for 3 months after treatment ends
  • Signed informed consent form
Not Eligible

You will not qualify if you...

  • Known allergy to any investigational drug
  • Resistance to azacitidine, Venetoclax, or Chidamide
  • Unable to take oral medication
  • Active uncontrolled infections (bacterial, fungal, or viral)
  • Uncontrolled major organ dysfunction such as cardiac insufficiency, decompensated liver insufficiency, or moderate/severe renal insufficiency
  • Participation in other clinical studies that interfere with this study's purpose
  • Deemed unsuitable by investigators for participation

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 13 locations

1

Dongguan General Hosptial

Dongguan, Guangdong, China

Actively Recruiting

2

Foshan First People's Hospital

Foshan, Guangdong, China

Actively Recruiting

3

Guangdong Provincial People's Hospital

Guangzhou, Guangdong, China, 510080

Actively Recruiting

4

Sun Yat-sen University Cancer Center

Guangzhou, Guangdong, China

Actively Recruiting

5

The Fifth Affiliated Hospital of Guangzhou Medical University

Guangzhou, Guangdong, China

Actively Recruiting

6

The First Affiliated Hospital of Guangdong Pharmaceutical University

Guangzhou, Guangdong, China

Actively Recruiting

7

The First Affiliated Hospital of Guangzhou Medical University

Guangzhou, Guangdong, China

Actively Recruiting

8

The First Affiliated Hospital of Jinan University

Guangzhou, Guangdong, China

Actively Recruiting

9

The Second Affiliated Hospital of Guangzhou Medical University

Guangzhou, Guangdong, China

Actively Recruiting

10

Shenzhen second people's Hospital

Shenzhen, Guangdong, China

Actively Recruiting

11

Affiliated Hospital of Guangdong Medical University

Zhanjiang, Guangdong, China

Actively Recruiting

12

Zhuhai General Hosptial

Zhuhai, Guangdong, China

Actively Recruiting

13

Hainan General Hosptial

Haikou, Hainan, China

Actively Recruiting

Loading map...

Research Team

J

Jianyu Weng

CONTACT

D

Du Xin

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here